Treatment for liver metastases typically aims to alleviate symptoms and increase life expectancy. In most cases, there is no way to cure liver metastases.

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Yttrium-90 resin microspheres selective internal radiation therapy (90Y-SIRT) is a potent treatment for patients with liver metastases due to gastrointestinal stromal tumors (GIST) resistant to TKI ...

Adding Radiation Improves Embolization for Liver Metastases Unlike primary liver cancer, metastatic liver tumors often do not respond to embolization alone. For these cases, IR specialists may add a ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.

The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy, to be made available on the NHS.